| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.005 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.005 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.71 | 0.007 |